Drug Database
Back to search

France· FR:61312477

TELZIR 700 mg, comprimé pelliculé

A fosamprenavir product containing fosamprénavir calcique, registered in France by VIIV HEALTHCARE UK (ROYAUME-UNI), on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J05AE07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedTELZIR 700 mg, comprimé pelliculéATCJ05AE07REGISTER NO.FR:61312477PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fosamprénavir calciqueAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fosamprenavir is registered in 8 of 19 countries.

Countries holding a registration under ATC J05AE07 (fosamprenavir), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 6 of them publish a price we can compare per daily dose
Search fosamprenavir products by name

Fosamprenavir · ATC J05AE07

8 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fosamprenavir costs, country by country.

Normalised to the WHO defined daily dose (1.4 g), so markets compare like for like.

  • France: $13.86 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Fosamprenavir · price per daily dose (1.4 g)

USD · FX 28 Sept 2026

  • FR France$13.86
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FOSAMPRÉNAVIR CALCIQUE
Manufacturer
VIIV HEALTHCARE UK (ROYAUME-UNI)
Country
France (FR)
ATC code
J05AE07
ATC class
Fosamprenavir
Defined daily dose
1.4 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400936406391
    flacon(s) polyéthylène haute densité (PEHD) de 60 comprimé(s) avec fermeture de sécurité enfant
    EUR 365.27

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

336 interactions on record for fosamprenavir.

Graded by severity as the source publishes them — 116 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fosamprenavir against other medicinesHow interaction checks work

Fosamprenavir · interactions on record

336 records

  • 116 severe
  • 186 moderate
  • 7 minor
  • 25 info

Most severe, free to view

  • CisaprideA03FA02severe
  • NaloxegolA06AH03severe
  • LoperamideA07DA03severe
  • BudesonideA07EA06severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fosamprenavir in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fosamprenavir products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/97713490-1803-4651-abf6-572ad002248d
GET /v1/drugs/97713490-1803-4651-abf6-572ad002248d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61312477",
  "date_amm": "2004-07-12",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/04/282",
  "substance": "FOSAMPRÉNAVIR CALCIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about fosamprenavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console